Popular:
Bio-Techne Corporation (TECH)
Intrinsic Value (DCF)
Current$69.96
→
Intrinsic$30.98
-56%
$20.61$30.98$50.69
Market implies 31% growth for 5 years
Current price reflects execution expectations above 11% growth — not unreasonable for quality businesses.
At $70, the market prices in continued strong cash flow growth (31%) — likely reflecting buybacks, margin stability, and ecosystem strength.
Range: Bear $21 → Bull $51. Current price implies expectations above the base case, closer to bull expectations.
| Discount ↓Growth → | 7% | 9% | 11% | 13% |
|---|---|---|---|---|
| 8% | $37 | $41 | $45 | $49 |
| 10% | $26 | $28 | $31 | $34 |
| 12% | $20 | $22 | $23 | $26 |
| 14% | $16 | $17 | $19 | $20 |
Bull Case
- Bull case ($51) with 13% growth, 9% discount rate
- Conservative 11% growth assumption is achievable based on track record
Bear Case
- Bear case ($21) implies 71% downside at 9% growth, 12% discount
- Price reflects 31% growth expectations vs 11% historical — high bar to clear
- Trading 56% above base case — execution must exceed assumptions to justify
Loading charts...
5-Year Free Cash Flow Projection
Year 1$284.32M
Year 2$315.09M
Year 3$349.19M
Year 4$386.98M
Year 5$428.86M
Terminal$6.31B
📐 Model Inputs
Growth Rate10.8%5Y CAGR (cascade: 5Y→3Y→TTM)
Discount Rate10.0%WACC estimate
Terminal Growth3.0%Perpetuity rate
Base Free Cash Flow$256.55MTTM actual
Bear g×0.8, r+2%
Base Historical CAGR
Bull g×1.2, r−1.5%
DCF estimates based on historical growth rates extrapolated forward. See FAQ below for full methodology.